An observational study assessing the management of gastrointestinal and urogenital bleeding events in patients with atrial fibrillation treated with dabigatran etexilate (GI/GU bleeding management in AF patients using dab) First published 21/11/2013 Last updated 30/03/2024 EU PAS number:EUPAS5214 Study Finalised
United BioSource Corporation (UBC) Switzerland First published:25/04/2013 Last updated 06/03/2024 Institution Non-Pharmaceutical company ENCePP partner